Ambispective Observational Study to Evaluate the Incidence and Management of Aplastic Anemia in Spain
NCT04001686 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 109
Last updated 2021-08-10
Summary
This is a national, multicenter, ambispective, observational post-authorization study (EPA-SP for its acronym in Spanish) to describe the incidence, clinical management and outcome of aplastic anemia in hospitals throughout Spain.
Conditions
- Aplastic Anemia
Interventions
- OTHER
-
incidence aplastic anemia
Ambispective chart review
Sponsors & Collaborators
-
Biogipuzkoa Health Research Institute
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-31
- Primary Completion
- 2021-09-01
- Completion
- 2022-09-30
Countries
- Spain
Study Locations
More Related Trials
-
Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia
NCT07010237 ·Status: RECRUITING ·Phase: PHASE2
-
Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid
NCT00437450 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Study the Efficacy and Safety of Rh-EPO in the Treatment of Anemia in Lymphoma
NCT04910594 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia
NCT07075484 ·Status: COMPLETED ·Phase: PHASE1
-
Apotransferrin in Patients With β-thalassemia
NCT03993613 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Observe the Number of Patients Who Develop Pure Red Cell Aplasia (PRCA, a Rare Form of Anemia) While Receiving Epoetin Alfa or Other Recombinant Erythropoietins
NCT00211029 ·Status: COMPLETED
-
Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia Among Patients With Chronic Kidney Failure
NCT00391287 ·Status: COMPLETED
-
Apotransferrin in Atransferrinemia
NCT01797055 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of APG-5918.
NCT05773586 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of Intravenous or Subcutaneous Methoxy Polyethylene Glycol-Epoetin Beta (RO0503821, Mircera) in Chronic Kidney Disease Patients With Renal Anemia
NCT00090753 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve
NCT03682536 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Erythropoietin Alfa in Elderly Subjects With Unexplained Anemia
NCT00954486 ·Status: WITHDRAWN ·Phase: NA
-
A Bioequivalence Study of Hetrombopag in Healthy Subjects
NCT05088655 ·Status: COMPLETED ·Phase: PHASE1
-
Prevalence of Erythropoiesis Stimulating Agents Hyporesponsiveness in Dialysis Patients in Assiut University Hospital
NCT06053866 ·Status: NOT_YET_RECRUITING
-
A Study of Risk Factors for Anti-erythropoietin Antibody Positive Pure Red Cell Aplasia Among Patients With Chronic Kidney Disease Receiving Epoetin Alfa
NCT00211068 ·Status: COMPLETED
-
ASP1517 Phase 2 Clinical Trial - Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis-
NCT01964196 ·Status: COMPLETED ·Phase: PHASE2
-
Biosimilarity Study of Intravenous Recombinant Human Erythropoietin in Healthy Volunteers
NCT04954989 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Study on the Short-term Efficacy and Safety of Recombinant Human Thrombopoietin Combined With Immunosuppressant Sequential Eltrombopag Ethanolamine Dry Suspension in the Treatment of SAA/TD-NSAA
NCT07001397 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Herombopag Added to Cyclosporine in Non Severe Aplastic Anemia
NCT05660785 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin
NCT01628107 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Patients Treated With Erythropoietin Receptor Agonists for Anemia Who Developed Anti-erythropoietin Antibodies
NCT00210977 ·Status: WITHDRAWN
-
Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens
NCT05704894 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA)
NCT02612558 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety Extension Study in Patients With Erythropoietic Protoporphyria (EPP)
NCT04578496 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3, Long-Term Safety Study of Subcutaneous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME -Anemia Management With Epoetin
NCT01628120 ·Status: COMPLETED ·Phase: PHASE3